Dayal Sujata Tyagi
SEC insider (Form 3/4/5 filer). CIK 0001536908. Director at Emergent BioSolutions Inc. (EBS). 5 reported Form 4/5 transactions since Sep 2024; latest on May 1, 2026. Located in GAITHERSBURG, MD.
Companies Dayal Sujata Tyagi has filed insider reports for
- Emergent BioSolutions Inc. (EBS): Director
Dayal Sujata Tyagi
CIK: 0001536908
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)3 (60.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (40.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
EBS
Emergent BioSolutions Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- May 1, 2026EBS
Emergent BioSolutions Inc.
SaleDirect12.8K shares at avg. $8.36$107K - May 1, 2026EBS
Emergent BioSolutions Inc.
SaleDirect980 shares at avg. $8.94$9K - Apr 30, 2026EBS
Emergent BioSolutions Inc.
AwardDirect25.3K shares- - Nov 7, 2025EBS
Emergent BioSolutions Inc.
SaleDirect8.6K shares at avg. $10.00$86K - Apr 30, 2025EBS
Emergent BioSolutions Inc.
AwardDirect34.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 1, 2026 | EBS Emergent BioSolutions Inc. | Sale | 12,781 | $8.36 | $106,849 | Direct |
| May 1, 2026 | EBS Emergent BioSolutions Inc. | Sale | 980 | $8.94 | $8,761 | Direct |
| Apr 30, 2026 | EBS Emergent BioSolutions Inc. | Award | 25,344 | - | $0 | Direct |
| Nov 7, 2025 | EBS Emergent BioSolutions Inc. | Sale | 8,552 | $10.00 | $85,520 | Direct |
| Apr 30, 2025 | EBS Emergent BioSolutions Inc. | Award | 34,403 | - | - | Direct |
1-5 of 5 transactions